Literature DB >> 26100672

CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.

Mike R Russell1, Annalise Penikis1, Derek A Oldridge1, Juan R Alvarez-Dominguez2, Lee McDaniel1, Maura Diamond1, Olivia Padovan3, Pichai Raman4, Yimei Li1, Jun S Wei5, Shile Zhang5, Janahan Gnanchandran6, Robert Seeger6, Shahab Asgharzadeh6, Javed Khan5, Sharon J Diskin7, John M Maris7, Kristina A Cole8.   

Abstract

Chromosome 6p22 was identified recently as a neuroblastoma susceptibility locus, but its mechanistic contributions to tumorigenesis are as yet undefined. Here we report that the most highly significant single-nucleotide polymorphism (SNP) associations reside within CASC15, a long noncoding RNA that we define as a tumor suppressor at 6p22. Low-level expression of a short CASC15 isoform (CASC15-S) associated highly with advanced neuroblastoma and poor patient survival. In human neuroblastoma cells, attenuating CASC15-S increased cellular growth and migratory capacity. Gene expression analysis revealed downregulation of neuroblastoma-specific markers in cells with attenuated CASC15-S, with concomitant increases in cell adhesion and extracellular matrix transcripts. Altogether, our results point to CASC15-S as a mediator of neural growth and differentiation, which impacts neuroblastoma initiation and progression. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26100672      PMCID: PMC4526355          DOI: 10.1158/0008-5472.CAN-14-3613

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

Review 1.  Genome regulation by long noncoding RNAs.

Authors:  John L Rinn; Howard Y Chang
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

2.  A linear complexity phasing method for thousands of genomes.

Authors:  Olivier Delaneau; Jonathan Marchini; Jean-François Zagury
Journal:  Nat Methods       Date:  2011-12-04       Impact factor: 28.547

3.  Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.

Authors:  Jan J Molenaar; Jan Koster; Danny A Zwijnenburg; Peter van Sluis; Linda J Valentijn; Ida van der Ploeg; Mohamed Hamdi; Johan van Nes; Bart A Westerman; Jennemiek van Arkel; Marli E Ebus; Franciska Haneveld; Arjan Lakeman; Linda Schild; Piet Molenaar; Peter Stroeken; Max M van Noesel; Ingrid Ora; Evan E Santo; Huib N Caron; Ellen M Westerhout; Rogier Versteeg
Journal:  Nature       Date:  2012-02-22       Impact factor: 49.962

4.  Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions.

Authors:  Ci Chu; Kun Qu; Franklin L Zhong; Steven E Artandi; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-29       Impact factor: 17.970

5.  Childhood cancer and developmental biology a crucial partnership.

Authors:  Sara Federico; Rachel Brennan; Michael A Dyer
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

6.  Association of age at diagnosis and genetic mutations in patients with neuroblastoma.

Authors:  Nai-Kong V Cheung; Jinghui Zhang; Charles Lu; Matthew Parker; Armita Bahrami; Satish K Tickoo; Adriana Heguy; Alberto S Pappo; Sara Federico; James Dalton; Irene Y Cheung; Li Ding; Robert Fulton; Jianmin Wang; Xiang Chen; Jared Becksfort; Jianrong Wu; Catherine A Billups; David Ellison; Elaine R Mardis; Richard K Wilson; James R Downing; Michael A Dyer
Journal:  JAMA       Date:  2012-03-14       Impact factor: 56.272

Review 7.  The emergence of lncRNAs in cancer biology.

Authors:  John R Prensner; Arul M Chinnaiyan
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

8.  Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans.

Authors:  Valeria Latorre; Sharon J Diskin; Maura A Diamond; Haitao Zhang; Hakon Hakonarson; John M Maris; Marcella Devoto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-10       Impact factor: 4.254

9.  Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.

Authors:  Le B Nguyen; Sharon J Diskin; Mario Capasso; Kai Wang; Maura A Diamond; Joseph Glessner; Cecilia Kim; Edward F Attiyeh; Yael P Mosse; Kristina Cole; Achille Iolascon; Marcella Devoto; Hakon Hakonarson; Hongzhe K Li; John M Maris
Journal:  PLoS Genet       Date:  2011-03-17       Impact factor: 5.917

10.  Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.

Authors:  Sharon J Diskin; Mario Capasso; Robert W Schnepp; Kristina A Cole; Edward F Attiyeh; Cuiping Hou; Maura Diamond; Erica L Carpenter; Cynthia Winter; Hanna Lee; Jayanti Jagannathan; Valeria Latorre; Achille Iolascon; Hakon Hakonarson; Marcella Devoto; John M Maris
Journal:  Nat Genet       Date:  2012-09-02       Impact factor: 38.330

View more
  76 in total

1.  Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis.

Authors:  Chaoqun Huang; Yurong Liang; Xiangming Zeng; Xiaoyun Yang; Dao Xu; Xuxu Gou; Roshini Sathiaseelan; Lakmini Kumari Senavirathna; Pengcheng Wang; Lin Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2020-04       Impact factor: 6.914

2.  Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma.

Authors:  Laura E Egolf; Zalman Vaksman; Gonzalo Lopez; Jo Lynne Rokita; Apexa Modi; Patricia V Basta; Hakon Hakonarson; Andrew F Olshan; Sharon J Diskin
Journal:  Am J Hum Genet       Date:  2019-08-29       Impact factor: 11.025

3.  CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma.

Authors:  Yue Xing; Xuyang Wen; Xia Ding; Jiayan Fan; Peiwei Chai; Renbing Jia; Shengfang Ge; Guanxiang Qian; He Zhang; Xianqun Fan
Journal:  Mol Ther       Date:  2017-03-18       Impact factor: 11.454

4.  Long-noncoding RNAs in basal cell carcinoma.

Authors:  Michael Sand; Falk G Bechara; Daniel Sand; Thilo Gambichler; Stephan A Hahn; Michael Bromba; Eggert Stockfleth; Schapoor Hessam
Journal:  Tumour Biol       Date:  2016-02-09

5.  Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.

Authors:  Kathleen Conway; Sharon N Edmiston; Joel S Parker; Pei Fen Kuan; Yi-Hsuan Tsai; Pamela A Groben; Daniel C Zedek; Glynis A Scott; Eloise A Parrish; Honglin Hao; Michelle V Pearlstein; Jill S Frank; Craig C Carson; Matthew D Wilkerson; Xiaobei Zhao; Nathaniel A Slater; Stergios J Moschos; David W Ollila; Nancy E Thomas
Journal:  J Invest Dermatol       Date:  2018-12-06       Impact factor: 8.551

6.  Nervous system: Embryonal tumors: Neuroblastoma.

Authors:  Caileigh Pudela; Skye Balyasny; Mark A Applebaum
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2020-07

7.  Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis.

Authors:  Xianglong Tian; Xiaoqiang Zhu; Tingting Yan; Chenyang Yu; Chaoqin Shen; Jie Hong; Haoyan Chen; Jing-Yuan Fang
Journal:  J Cancer       Date:  2017-08-03       Impact factor: 4.207

Review 8.  Genetic discoveries and treatment advances in neuroblastoma.

Authors:  Rochelle Bagatell; Susan L Cohn
Journal:  Curr Opin Pediatr       Date:  2016-02       Impact factor: 2.856

9.  Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.

Authors:  Eric A Hungate; Mark A Applebaum; Andrew D Skol; Zalman Vaksman; Maura Diamond; Lee McDaniel; Samuel L Volchenboum; Barbara E Stranger; John M Maris; Sharon J Diskin; Kenan Onel; Susan L Cohn
Journal:  J Natl Cancer Inst       Date:  2017-10-01       Impact factor: 13.506

10.  Evaluation of GWAS-identified SNPs at 6p22 with neuroblastoma susceptibility in a Chinese population.

Authors:  Jing He; Ruizhong Zhang; Yan Zou; Jinhong Zhu; Tianyou Yang; Fenghua Wang; Huimin Xia
Journal:  Tumour Biol       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.